Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 444 record(s)

Req # A-2023-000857

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-075026-750.

Organization: Health Canada

13 page(s)
October 2023

Req # A-2023-000859

Adverse Drug Reaction (ADR). Report number: 001038970.

Organization: Health Canada

1 page(s)
October 2023

Req # A-2023-000869

Adverse Drug Reactions (ADRs). Report numbers: 001032877, 001034437, 001034838, 001038896, 001042304, 001035863, 001038090, 001039491, 001042722.

Organization: Health Canada

42 page(s)
October 2023

Req # A-2023-000882

Adverse Drug Reaction (ADR). Report number: 001039714.

Organization: Health Canada

2 page(s)
October 2023

Req # A-2023-000898

Adverse Drug Reactions (ADRs) for BENADRYL. Report numbers: 001025260, 001050026. ADRs for REACTINE. Report numbers: 001020501, 001032539. ADRs for TYLENOL. Report numbers: 001015816, 001021323, 001021598, 001025911. ADR for BENZOCAINE. Report number: 001016740.

Organization: Health Canada

49 page(s)
October 2023

Req # A-2023-000899

Adverse Drug Reactions (ADRs) for ACETAMINOPHEN. Report numbers: 001029707, 001035137, 001037832.

Organization: Health Canada

23 page(s)
October 2023

Req # A-2023-000902

Adverse Drug Reactions (ADRs) for MOTRIN. Report numbers: 001048236, 001048837, 001049292, 001049949, 001049969, 001050122.

Organization: Health Canada

18 page(s)
October 2023

Req # A-2023-000904

Adverse Drug Reactions (ADRs) for IBUPROFEN. Report numbers: 001013761, 001015268, 001018555, 001022658, 001023661, 001023706, 001028874, 001031987, 001038200, 001039630.

Organization: Health Canada

42 page(s)
October 2023

Req # A-2023-000906

Adverse Drug Reactions (ADRs) for IBUPROFEN. Report numbers: 001043002, 001047381, 001049982.

Organization: Health Canada

17 page(s)
October 2023

Req # AF-2022-00023

Regarding the Senakw development on Kitsilano IR 6 in Vancouver (involving Squamish Nation/Nch’kay/Westbank) I seek the project business case (including financials), cost/benefit analysis,environmental study, land use and transportation analysis, shadow studies, architectural drawings, site design,building plans and related applications and approvals.

Organization: Canada Mortgage and Housing Corporation

0 page(s)
October 2022
Date modified: